I am excited to bring this new issue of Countdown to our readers. It is an issue that speaks profoundly to the core mission of JDRF—research. At the heart of what we do is our dedication and commitment to discover, develop, and deliver advances that cure, better treat, and prevent type 1 diabetes (T1D). As we work […]
Countdown is written and produced by our Marketing and Communications team here at JDRF. As the leader of the team and JDRF’s chief marketing officer, I am pleased to bring our new issue to you. We have so much news and information to share—and it is our hope that you will share it with everyone you […]
By Susan Learner Barr, M.S., R.D. There’s no end to what you can learn when visiting our nation’s capital. On February 18, more than 600 people, all sharing a connection to type 1 diabetes (T1D), attended the 2012 JDRF Type 1 Diabetes Research Summit hosted by the JDRF Capitol Chapter. A letter in the summit […]
By Susan Learner Barr, M.S., R.D. In type 1 diabetes (T1D), to have good control of your blood-glucose levels, you need to learn how to count carbohydrates (CHO). That’s right, counting CHO is pretty much T1D “Diet 101.” First you learn that CHO are the main source of energy for your body—they are broken down […]
By Jeffrey Brewer When JDRF was asked to submit an article to Diabetes, a medical journal of the American Diabetes Association (ADA), our organization’s leaders recognized the superb opportunity offered by this request. As a result, “Juvenile Diabetes Research Foundation: Mission, Strategy, and Priorities” was published in the January 2012 issue ofDiabetes in the journal’s “Perspectives in […]
By Susan Learner Barr, M.S., R.D. Many people with type 1 diabetes (T1D) maintain a healthy weight and do not have to think about losing a pound. However, some individuals with T1D, and the majority of the adult population in the United States, do have to be mindful of the number on the scale. And […]
Researchers supported by JDRF recently characterized for the first time the nature of the encounter between killer T cells and their targets—the insulin-producing beta cells in the pancreas. Using an actual T cell that was replicated or “cloned” from a patient with type 1 diabetes (T1D), the
researchers provided valuable evidence about the interaction that takes place on a molecular level and contributes to the autoimmune attack that destroys beta cells. These findings can help guide the development of targeted therapies for the prevention of T1D.
Researchers recently demonstrated for the first time a direct association between human beta cell destruction and CD8 T cells, which are cells that play an important role in the body’s immune system. This autoimmune “attack” is a hallmark of T1D and it results in the destruction of insulin-producing beta cells in the pancreas. In their investigation, the researchers used human tissue samples from the pancreases of T1D organ donors obtained through nPOD, a JDRF collaborative research project. This new study provides evidence that CD8 T cells are present in the islets of the pancreas that contain beta cells. These findings are important for future research on preserving beta-cell function and establishing biomarkers for therapies for T1D.
My nine-year-old daughter was diagnosed with type 1 diabetes (T1D) five days ago. We are a military family currently stationed in South Korea. We are with very few English resources in the area. It looks like we will get an emergency move to our next duty station in El Paso, TX, in a couple of weeks. How do we find quality care in a foreign country, manage an international move with a child with T1D, and find quality care to deal with a new diagnosis?